{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T04:52:36Z","timestamp":1767847956090,"version":"3.49.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":3593,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbes and Infection"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.micinf.2013.11.009","type":"journal-article","created":{"date-parts":[[2013,11,27]],"date-time":"2013-11-27T02:16:46Z","timestamp":1385518606000},"page":"244-252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["A vaccine formulated with a combination of TLR-2 and TLR-9 adjuvants and the recombinant major outer membrane protein elicits a robust immune response and significant protection against a Chlamydia muridarum challenge"],"prefix":"10.1016","volume":"16","author":[{"given":"Chunmei","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sukumar","family":"Pal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delia","family":"Tifrea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenyu","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis M.","family":"de la Maza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.micinf.2013.11.009_bib1","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1001\/jama.291.18.2229","article-title":"Prevalence of chlamydial and gonococcal infections among young adults in the United States","volume":"291","author":"Miller","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.micinf.2013.11.009_bib2","series-title":"Human chlamydial infections","author":"Schachter","year":"1978"},{"key":"10.1016\/j.micinf.2013.11.009_bib3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/01.olq.0000187205.67390.d1","article-title":"Prediction of pelvic inflammatory disease among young, single, sexually active women","volume":"33","author":"Ness","year":"2006","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.micinf.2013.11.009_bib4","series-title":"Sexually transmitted diseases","first-page":"575","article-title":"Chlamydia trachomatis infections of the adult","author":"Stamm","year":"2008"},{"key":"10.1016\/j.micinf.2013.11.009_bib5","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1053\/j.spid.2005.06.004","article-title":"Chlamydia trachomatis infections in neonates and young children","volume":"16","author":"Darville","year":"2005","journal-title":"Semin Pediatr Infect Dis"},{"key":"10.1016\/j.micinf.2013.11.009_bib6","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S0022-3476(84)80554-5","article-title":"Chlamydia trachomatis as a cause of pneumonitis and pleural effusion","volume":"104","author":"Stutman","year":"1984","journal-title":"J Pediatr"},{"key":"10.1016\/j.micinf.2013.11.009_bib7","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00007435-199207000-00001","article-title":"Pelvic inflammatory disease and fertility. A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results","volume":"19","author":"Westrom","year":"1992","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.micinf.2013.11.009_bib8","series-title":"Trachoma: a blinding Scourge from the Bronze age to the Twenty-first Century","author":"Taylor","year":"2008"},{"key":"10.1016\/j.micinf.2013.11.009_bib9","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1086\/497341","article-title":"The unexpected impact of a Chlamydia trachomatis infection control program on susceptibility to reinfection","volume":"192","author":"Brunham","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.micinf.2013.11.009_bib10","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1080\/00365540110077001","article-title":"Is the increase in notifications of Chlamydia trachomatis infections in Sweden the result of changes in prevalence, sampling frequency or diagnostic methods?","volume":"34","author":"Gotz","year":"2002","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.micinf.2013.11.009_bib11","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0264-410X(95)80022-6","article-title":"A new computer model for estimating the impact of vaccination protocols and its application to the study of Chlamydia trachomatis genital infections","volume":"13","author":"de la Maza","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2013.11.009_bib12","first-page":"980","article-title":"Vaccines for Chlamydia trachomatis infections","volume":"3","author":"de la Maza","year":"2002","journal-title":"Curr Opin Invest Drugs"},{"key":"10.1016\/j.micinf.2013.11.009_bib13","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1128\/IAI.00881-10","article-title":"Vaccination against Chlamydia genital infection utilizing the murine C. muridarum model","volume":"79","author":"Farris","year":"2011","journal-title":"Infect Immun"},{"key":"10.1016\/j.micinf.2013.11.009_bib14","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/nature04596","article-title":"Toll-dependent selection of microbial antigens for presentation by dendritic cells","volume":"440","author":"Blander","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.micinf.2013.11.009_bib15","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nri2038","article-title":"Cooperation of toll-like receptor signals in innate immune defence","volume":"7","author":"Trinchieri","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.micinf.2013.11.009_bib16","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1586\/14760584.8.3.293","article-title":"Vaccine adjuvants: scientific challenges and strategic initiatives","volume":"8","author":"Harandi","year":"2009","journal-title":"Expert Rev Vaccines"},{"issue":"Suppl. 2","key":"10.1016\/j.micinf.2013.11.009_bib17","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1016\/S0264-410X(03)00206-8","article-title":"Mucosal immunisation and adjuvants: a brief overview of recent advances and challenges","volume":"21","author":"Holmgren","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2013.11.009_bib18","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.intimp.2008.03.005","article-title":"Adjuvant formulations possess differing efficacy in the potentiation of antibody and cell mediated responses to a human malaria vaccine under selective immune genes knockout environment","volume":"8","author":"Hui","year":"2008","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.micinf.2013.11.009_bib19","doi-asserted-by":"crossref","first-page":"6641","DOI":"10.1016\/j.vaccine.2011.06.105","article-title":"A TLR2 agonist is a more effective adjuvant for a Chlamydia major outer membrane protein vaccine than ligands to other TLR and NOD receptors","volume":"29","author":"Cheng","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2013.11.009_bib20","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/eji.200424955","article-title":"Toll-like receptor 6-independent signaling by diacylated lipopeptides","volume":"35","author":"Buwitt-Beckmann","year":"2005","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.micinf.2013.11.009_bib21","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.cell.2007.09.008","article-title":"Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide","volume":"130","author":"Jin","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.micinf.2013.11.009_bib22","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiq176","article-title":"Murine Chlamydia trachomatis genital infection is unaltered by depletion of CD4+ t cells and diminished adaptive immunity","author":"Morrison","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.micinf.2013.11.009_bib23","doi-asserted-by":"crossref","first-page":"870","DOI":"10.4049\/jimmunol.160.2.870","article-title":"CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen","volume":"160","author":"Davis","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.micinf.2013.11.009_bib24","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0264-410X(99)00526-5","article-title":"CpG DNA induces stronger immune responses with less toxicity than other adjuvants","volume":"18","author":"Weeratna","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2013.11.009_bib25","doi-asserted-by":"crossref","first-page":"8153","DOI":"10.1128\/IAI.73.12.8153-8160.2005","article-title":"Vaccination with the Chlamydia trachomatis major outer membrane protein can elicit an immune response as protective as that resulting from inoculation with live bacteria","volume":"73","author":"Pal","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.micinf.2013.11.009_bib26","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1128\/iai.31.3.1161-1176.1981","article-title":"Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis","volume":"31","author":"Caldwell","year":"1981","journal-title":"Infect Immun"},{"key":"10.1016\/j.micinf.2013.11.009_bib27","doi-asserted-by":"crossref","first-page":"5020","DOI":"10.1016\/j.vaccine.2009.05.008","article-title":"Protection against an intranasal challenge by vaccines formulated with native and recombinant preparations of the Chlamydia trachomatis major outer membrane protein","volume":"27","author":"Sun","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2013.11.009_bib28","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1128\/iai.62.6.2432-2439.1994","article-title":"Expression of large amounts of neisserial porin proteins in Escherichia coli and refolding of the proteins into native trimers","volume":"62","author":"Qi","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.micinf.2013.11.009_bib29","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/0003-2697(87)90587-2","article-title":"Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100\u00a0kDa","volume":"166","author":"Schagger","year":"1987","journal-title":"Anal Biochem"},{"key":"10.1016\/j.micinf.2013.11.009_bib30","doi-asserted-by":"crossref","first-page":"50","DOI":"10.7774\/cevr.2012.1.1.50","article-title":"Mucosal vaccine adjuvants update","volume":"1","author":"Rhee","year":"2012","journal-title":"Clin Exp Vaccine Res"},{"key":"10.1016\/j.micinf.2013.11.009_bib31","doi-asserted-by":"crossref","first-page":"6239","DOI":"10.1016\/j.vaccine.2009.07.108","article-title":"Induction of protective immunity by vaccination against Chlamydia trachomatis using the major outer membrane protein adjuvanted with CpG oligodeoxynucleotide coupled to the nontoxic B subunit of cholera toxin","volume":"27","author":"Cheng","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2013.11.009_bib32","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1128\/iai.62.8.3354-3362.1994","article-title":"Protection against infertility in a BALB\/c mouse salpingitis model by intranasal immunization with the mouse pneumonitis biovar of Chlamydia trachomatis","volume":"62","author":"Pal","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.micinf.2013.11.009_bib33","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1016\/j.vaccine.2010.12.117","article-title":"Intranasal vaccination with pneumococcal surface protein A plus poly(I: C) protects against secondary pneumococcal pneumonia in mice","volume":"29","author":"Ezoe","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2013.11.009_bib34","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.1128\/IAI.70.9.4812-4817.2002","article-title":"Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein by use of CpG oligodeoxynucleotides as an adjuvant induces a protective immune response against an intranasal chlamydial challenge","volume":"70","author":"Pal","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.micinf.2013.11.009_bib35","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1002\/1521-4141(200204)32:4<1188::AID-IMMU1188>3.0.CO;2-A","article-title":"Non-LPS components of Chlamydia pneumoniae stimulate cytokine production through toll-like receptor 2-dependent pathways","volume":"32","author":"Netea","year":"2002","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.micinf.2013.11.009_bib36","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.4049\/jimmunol.180.2.1158","article-title":"The proinflammatory cytokine response to Chlamydia trachomatis elementary bodies in human macrophages is partly mediated by a lipoprotein, the macrophage infectivity potentiator, through TLR2\/TLR1\/TLR6 and CD14","volume":"180","author":"Bas","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.micinf.2013.11.009_bib37","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1128\/IAI.01118-10","article-title":"Toll-like receptor 2 activation by Chlamydia trachomatis is plasmid dependent, and plasmid-responsive chromosomal loci are coordinately regulated in response to glucose limitation by C. trachomatis but not by C. muridarum","volume":"79","author":"O'Connell","year":"2011","journal-title":"Infect Immun"},{"key":"10.1016\/j.micinf.2013.11.009_bib38","doi-asserted-by":"crossref","first-page":"450","DOI":"10.4049\/jimmunol.175.1.450","article-title":"Chlamydia trachomatis induces expression of IFN-gamma-inducible protein 10 and IFN-beta independent of TLR2 and TLR4, but largely dependent on MyD88","volume":"175","author":"Nagarajan","year":"2005","journal-title":"J Immunol"},{"issue":"Suppl. B","key":"10.1016\/j.micinf.2013.11.009_bib39","first-page":"83","article-title":"TLR9 KO mice, haplotypes and CPG indices in Chlamydia trachomatis infection","volume":"45","author":"Ouburg","year":"2009","journal-title":"Drugs Today (Barc)"},{"key":"10.1016\/j.micinf.2013.11.009_bib40","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.01062-12","article-title":"TLR2-dependent activity of Chlamydia trachomatis native major outer membrane protein proteosomes","author":"Massari","year":"2013","journal-title":"Infect Immun"},{"key":"10.1016\/j.micinf.2013.11.009_bib41","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1021\/mp300257x","article-title":"Intranasal administration of the TLR2 agonist Pam2Cys provides rapid protection against influenza in mice","volume":"9","author":"Tan","year":"2012","journal-title":"Mol Pharm"},{"key":"10.1016\/j.micinf.2013.11.009_bib42","first-page":"141","article-title":"CpG DNA as a potent inducer of mucosal immunity: implications for immunoprophylaxis and immunotherapy of mucosal infections","volume":"5","author":"Harandi","year":"2004","journal-title":"Curr Opin Invest Drugs"},{"key":"10.1016\/j.micinf.2013.11.009_bib43","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nri2587","article-title":"A cell biological view of toll-like receptor function: regulation through compartmentalization","volume":"9","author":"Barton","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.micinf.2013.11.009_bib44","doi-asserted-by":"crossref","first-page":"5276","DOI":"10.1016\/j.vaccine.2011.05.013","article-title":"Induction of protection against vaginal shedding and infertility by a recombinant Chlamydia vaccine","volume":"29","author":"Carmichael","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2013.11.009_bib45","doi-asserted-by":"crossref","first-page":"5341","DOI":"10.1128\/iai.64.12.5341-5348.1996","article-title":"Intranasal immunization induces long-term protection in mice against a Chlamydia trachomatis genital challenge","volume":"64","author":"Pal","year":"1996","journal-title":"Infect Immun"},{"key":"10.1016\/j.micinf.2013.11.009_bib46","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa030595","article-title":"Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland","volume":"350","author":"Mutsch","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.micinf.2013.11.009_bib47","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1073\/pnas.0708684105","article-title":"Sublingual vaccination with influenza virus protects mice against lethal viral infection","volume":"105","author":"Song","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.micinf.2013.11.009_bib48","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.vaccine.2007.11.071","article-title":"Colonic antigen administration induces significantly higher humoral levels of colonic and vaginal IgA, and serum IgG compared to oral administration","volume":"26","author":"McConnell","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2013.11.009_bib49","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1016\/j.vaccine.2011.01.031","article-title":"Induction of protection in mice against a respiratory challenge by a vaccine formulated with the Chlamydia major outer membrane protein adjuvanted with IC31(R)","volume":"29","author":"Cheng","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2013.11.009_bib50","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1016\/j.vaccine.2005.11.008","article-title":"The HIV-1 matrix protein p17 can be efficiently delivered by intranasal route in mice using the TLR 2\/6 agonist MALP-2 as mucosal adjuvant","volume":"24","author":"Becker","year":"2006","journal-title":"Vaccine"}],"container-title":["Microbes and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1286457913002517?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1286457913002517?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T14:33:04Z","timestamp":1761143584000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1286457913002517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S1286457913002517"],"URL":"https:\/\/doi.org\/10.1016\/j.micinf.2013.11.009","relation":{},"ISSN":["1286-4579"],"issn-type":[{"value":"1286-4579","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A vaccine formulated with a combination of TLR-2 and TLR-9 adjuvants and the recombinant major outer membrane protein elicits a robust immune response and significant protection against a Chlamydia muridarum challenge","name":"articletitle","label":"Article Title"},{"value":"Microbes and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micinf.2013.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Institut Pasteur. Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}